← Insider buys
LTRN

Lantern Pharma Inc. · Healthcare

10% owner Aaron G.l. Fletcher sold $247K of Lantern Pharma Inc.

Sold$247,334
$4.20Price
58,889Shares
−4%Stake

What LTRN did after the filing

Filed Jan 19, copier in the same day
The stock from Fri, Jan 19 close, $4.04
+12.4%
S&P 500, same days
+6.2%

Measured over 30 trading days, to the Mar 4 close.

Traded Wed, Jan 17. Filed Fri, Jan 19, 11:31 AM ET, during the session. Returns use the Jan 19 close and the Mar 4 close. Not investment advice.